The Daily Papule

Meeting abstracts

BAD 2026

British Association of Dermatologists · Manchester, 30 June – 2 July 2026

639 abstracts, published in BJD on 26 June 2026.

  1. BI02

    Toxic epidermal necrolysis in an immunosuppressed patient on tumour necrosis factor-α inhibition: a role for interleukin-6 targeting

    Lim S, Guinan T, Hindle E

  2. BI11

    UK consensus guidelines for the management of immune checkpoint inhibitor-induced cutaneous toxicity

    Tookey P, Beer L, … senior author Muinonen-Martin A

  3. BI12

    Two skin diseases, one checkpoint inhibitor: cutaneous toxicity from pembrolizumab

    Tan XL, Goiriz R, … senior author Harwood C

  4. BI17

    Cutaneous disease in immunosuppressed haematology and oncology patients: implications for dermatology services

    Grechin C, Boyle A, Wynne B

  5. BI22

    Anti-TIF1-γ-positive dermatomyositis associated with pembrolizumab-treated breast cancer

    Ashcroft S, Watts S

  6. BI23

    Skin checks out: pembrolizumab-associated pemphigoid nodularis

    Modak R, Zamani A, … senior author Hadjimichael E

  7. BI25

    A change of heart: metastatic cutaneous squamous cell carcinoma in a renal transplant recipient

    Conlon O, Phelan A, … senior author Roche M

  8. BI27

    Eruptive naevi associated with encorafenib

    McFeely O, Molloy O

  9. BI30

    First UK-reported case of pembrolizumab-induced reactive perforating collagenosis

    Tomy S, Ahmed H, … senior author Lam M

  10. BI32

    Anti-programmed death 1 inhibitor-induced squamoproliferative eruption: a rare side effect

    Crous M, Mostert B, … senior author Ahmad K

  11. BI33

    Localized granulomatous reaction on the hand secondary to combination dabrafenib and trametinib therapy for metastatic melanoma

    Gor D, Belgi A, Chong W

  12. BI39

    When pruritus signals toxicity: bullous eruption from high-dose methotrexate

    Stanciu M, Boyle A, … senior author NicDhonncha E

  13. BI46

    Acquired haemophilia A following biologic therapy for dermatological conditions: a systematic review of published case reports

    Alomar A, Al Lawati A, Almulla L

  14. BI48

    Delayed genital cutaneous necrosis after hyperthermic intraperitoneal chemotherapy as an under-recognized complication: a two-case series

    House E, Li Tan X, … senior author Chapman A

  15. CD28

    Allergic contact dermatitis to tetracaine (Ametop®) at a subcutaneous port-a-cath site in a child

    Gupta S, Sharma R, … senior author Tewari A

  16. DP23

    A vanishingly rare case of angiosarcoma

    Yiu D, Peake D, … senior author Bardhan A

  17. LY04

    Large-cell transformation of mycosis fungoides: analysis of presentation, treatment and outcomes from a UK tertiary centre

    Qazi E, Bashir A, … senior author Scarisbrick J

  18. LY08

    Real-world outcomes and survival with targeted and established systemic therapies in advanced-stage cutaneous T-cell lymphoma: an updated PROCLIPI analysis

    Peterknecht E, Bashir A, … senior author Scarisbrick J

  19. LY23

    Granulomatous mogamulizumab-associated rash mimicking disease progression in erythrodermic mycosis fungoides

    Victory L, Fagan N, … senior author Molloy K

  20. P038

    Guselkumab for pembrolizumab-induced psoriasis in a patient with metastatic melanoma

    Conlon O, Herlihy M, … senior author O’Kane, Eilis Ni Chinneide, Helen Barrett and Adrian Murphy M

  21. P046

    Dermatopathology in the diagnosis of chemotherapy- and immunotherapy-induced vasculitis presenting with extensive digital necrosis: a clinicopathological case

    Gomez Giraldo ZF, Vargas H, … senior author Rolon Cadena MC

  22. P097

    Cutaneous toxicity of antibody–drug conjugates: a real-world cohort of 503 patients across 15 agents

    Cawley A, Heelan K, Wong H

  23. P167

    Extensive café au lait melanocytic birthmarks with metastatic melanomas

    Carson L, Oliphant T, … senior author Rajan N

  24. P187

    Exploring the emerging novel therapeutic potential of chimeric antigen receptor T-cell immunotherapy for autoimmune skin disease: ‘immune reset’ potential

    Hussain H, Dubash F

  25. P188

    Single-cell RNA and T-cell receptor sequencing reveals novel regulatory mechanisms of CD8+ memory T-cell formation and identifies a marker of response to checkpoint inhibitor therapy in melanoma

    Micevic G

  26. P208

    Efficacy of mogamulizumab in cutaneous T-cell lymphoma: a systematic review and meta-analysis

    Lawal A, Heffel KK, … senior author Rangel AR

  27. P214

    No association found between metformin use and overall survival in adults with melanoma receiving immunotherapy: a global retrospective study of 3788 patients

    Joshy J, Olexson MP, … senior author Mistry K

That's every abstract.